Desarrollada por el CSIC, CiberAMP permite establecer correlaciones directas entre cambios en el número de copias de genes en las células tumorales y sus niveles de expresión
Read moreIn the CheckMate 915 study, it has been possible to see that in the adjuvant treatment of high-risk melanoma in stage IIIA-D or resected stage IV, the use of nivolumab as monotherapy is as effective a...
Read moreMeritxell Gironella will lead the Institute's contribution to the project, which is financed by Horizon Europe funding from the European Union’s Marie Sklodowska-Curie Actions programme. The project...
Read moreThe finding, on which the team led by Pedro Medina from the Center for Genomics and Oncology Research (GENYO) has been working since 2014, focuses on mutations that to date had gone unnoticed by the s...
Read moreSe trata de una técnica que permite a los genetistas analizar fragmentos muy grandes de ADN y detectar un número de alteraciones genómicas muy superior a las que se pueden ver con el resto de técn...
Read moreResearchers in dermatology and human chronic inflammation, has led a new study focusing on the molecular mechanisms of moderate-severe forms of the atopic dermatitis disease. They have identified diff...
Read moreInterview Dr. Mercedes Zurita, researcher at the Puerta de Hierro Hospital and head of the Cell Therapy Unit at this site, the only one in Spain to offer NC1 therapy for patients with spinal cord inju...
Read moreThe study, led by researchers from IDIBAPS and the University of Barcelona, shows that these modifications play a role in the deregulation of genes associated with the function of neuronal synapses
Read moreA study with the participation of IrsiCaixa and published in the journal Nature Medicine shows that starting the administration of an anti-HIV antibody and antiretroviral treatment at the same time wo...
Read moreResearchers focused on the search for new molecular information associated with the respiratory consequences of severe COVID-19 symptoms that progressed to acute respiratory distress syndrome (ARDS)....
Read moreEl equipo de investigación de Ramón García-Escudero, perteneciente al grupo Jesús M. Paramio del programa Mecanismos de Progresión Tumoral del CIBERONC ha publicado el primer modelo animal de car...
Read moreXeltis, a medtech company developing the most advanced polymer-based restorative cardiovascular devices, today announced very promising preliminary efficacy and safety results from one of the centers ...
Read more